Matches in SemOpenAlex for { <https://semopenalex.org/work/W4236034797> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W4236034797 endingPage "800" @default.
- W4236034797 startingPage "793" @default.
- W4236034797 abstract "Abstract We evaluated the potential role of photoradiation therapy with a benzoporphyrin derivative, monoacid ring A (BPD-MA), and dihematoporphyrin ether (DHE), for the ex vivo purging of residual tumor cells from autologous bone marrow (BM) grafts. BPD-MA and DHE photosensitizing activity was tested against two human large-cell lymphoma cell lines and colony-forming unit-leukemia (CFU-L) derived from patients with acute myelogenous leukemia (AML). In mixing experiments, 4-log elimination of tumor cell lines was observed after 1 hour of incubation with 75 ng/mL of BPD-MA or 30 minutes of treatment with 12.5 micrograms/mL of DHE followed by white light exposure. By comparison, using the same concentration of BPD-MA, the mean recovery of normal BM progenitors was 4% +/- 0.8% (mean +/- SD) for granulocyte- macrophage colony-forming unit (CFU-GM) and 5% +/- 0.8% for burst- forming unit-erythroid (BFU-E). Similarly, DHE treatment resulted in the recovery of 5.2% +/- 2% and 9.8% +/- 3% of CFU-GM and BFU-E, respectively. Furthermore, equivalently cytotoxic concentrations of both DHE and BPD-MA and light were found not to kill normal pluripotent stem cells in BM, as demonstrated by their survival in two-step long- term marrow culture at levels equal to untreated controls. The T- lymphoblastic leukemia cell line CEM and its vinblastine (VBL)- resistant subline CEM/VBL, along with the acute promyelocyte leukemia cell line HL-60 and its vincristine (VCR)-resistant subline HL-60/VCR, were also tested. BPD-MA at 75 ng/mL was able to provide a greater than 4-log elimination of the drug-sensitive cell lines, but only a 34% and 55% decrease of the drug-resistant HL-60/VCR and CEM/VBL cell lines, respectively. On the contrary, 12.5 micrograms/mL of DHE reduced the clonogenic growth of all the cell lines by more than 4 logs. Further experiments demonstrated decreased uptake of both BPD-MA and DHE by the resistant cell lines. However, all the cell lines took up more DHE than BPD-MA under similar experimental conditions. Our results demonstrate the preferential cytotoxicity of BPD-MA and DHE toward neoplastic cell lines and CFU-L from AML patients. In addition, DHE was slightly more effective in purging tumor cells expressing the p-170 glycoprotein. These results suggest that photoradiation with DHE would be useful for in vitro purging of residual drug-resistant leukemia and lymphoma cells." @default.
- W4236034797 created "2022-05-12" @default.
- W4236034797 creator A5003612357 @default.
- W4236034797 creator A5022566005 @default.
- W4236034797 creator A5029756384 @default.
- W4236034797 creator A5032791493 @default.
- W4236034797 creator A5035486518 @default.
- W4236034797 creator A5062048388 @default.
- W4236034797 creator A5083102150 @default.
- W4236034797 creator A5083190542 @default.
- W4236034797 creator A5091378068 @default.
- W4236034797 date "1993-02-01" @default.
- W4236034797 modified "2023-09-26" @default.
- W4236034797 title "Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cells" @default.
- W4236034797 doi "https://doi.org/10.1182/blood.v81.3.793.793" @default.
- W4236034797 hasPublicationYear "1993" @default.
- W4236034797 type Work @default.
- W4236034797 citedByCount "19" @default.
- W4236034797 countsByYear W42360347972014 @default.
- W4236034797 countsByYear W42360347972016 @default.
- W4236034797 crossrefType "journal-article" @default.
- W4236034797 hasAuthorship W4236034797A5003612357 @default.
- W4236034797 hasAuthorship W4236034797A5022566005 @default.
- W4236034797 hasAuthorship W4236034797A5029756384 @default.
- W4236034797 hasAuthorship W4236034797A5032791493 @default.
- W4236034797 hasAuthorship W4236034797A5035486518 @default.
- W4236034797 hasAuthorship W4236034797A5062048388 @default.
- W4236034797 hasAuthorship W4236034797A5083102150 @default.
- W4236034797 hasAuthorship W4236034797A5083190542 @default.
- W4236034797 hasAuthorship W4236034797A5091378068 @default.
- W4236034797 hasBestOaLocation W42360347971 @default.
- W4236034797 hasConcept C126322002 @default.
- W4236034797 hasConcept C153911025 @default.
- W4236034797 hasConcept C185592680 @default.
- W4236034797 hasConcept C201750760 @default.
- W4236034797 hasConcept C203014093 @default.
- W4236034797 hasConcept C2776694085 @default.
- W4236034797 hasConcept C2776755627 @default.
- W4236034797 hasConcept C2778041864 @default.
- W4236034797 hasConcept C2778461978 @default.
- W4236034797 hasConcept C2779429289 @default.
- W4236034797 hasConcept C2780007613 @default.
- W4236034797 hasConcept C2781107101 @default.
- W4236034797 hasConcept C28328180 @default.
- W4236034797 hasConcept C2909962599 @default.
- W4236034797 hasConcept C2911091166 @default.
- W4236034797 hasConcept C54355233 @default.
- W4236034797 hasConcept C71924100 @default.
- W4236034797 hasConcept C81885089 @default.
- W4236034797 hasConcept C86803240 @default.
- W4236034797 hasConceptScore W4236034797C126322002 @default.
- W4236034797 hasConceptScore W4236034797C153911025 @default.
- W4236034797 hasConceptScore W4236034797C185592680 @default.
- W4236034797 hasConceptScore W4236034797C201750760 @default.
- W4236034797 hasConceptScore W4236034797C203014093 @default.
- W4236034797 hasConceptScore W4236034797C2776694085 @default.
- W4236034797 hasConceptScore W4236034797C2776755627 @default.
- W4236034797 hasConceptScore W4236034797C2778041864 @default.
- W4236034797 hasConceptScore W4236034797C2778461978 @default.
- W4236034797 hasConceptScore W4236034797C2779429289 @default.
- W4236034797 hasConceptScore W4236034797C2780007613 @default.
- W4236034797 hasConceptScore W4236034797C2781107101 @default.
- W4236034797 hasConceptScore W4236034797C28328180 @default.
- W4236034797 hasConceptScore W4236034797C2909962599 @default.
- W4236034797 hasConceptScore W4236034797C2911091166 @default.
- W4236034797 hasConceptScore W4236034797C54355233 @default.
- W4236034797 hasConceptScore W4236034797C71924100 @default.
- W4236034797 hasConceptScore W4236034797C81885089 @default.
- W4236034797 hasConceptScore W4236034797C86803240 @default.
- W4236034797 hasIssue "3" @default.
- W4236034797 hasLocation W42360347971 @default.
- W4236034797 hasOpenAccess W4236034797 @default.
- W4236034797 hasPrimaryLocation W42360347971 @default.
- W4236034797 hasRelatedWork W1970500233 @default.
- W4236034797 hasRelatedWork W1986616025 @default.
- W4236034797 hasRelatedWork W2033212823 @default.
- W4236034797 hasRelatedWork W2035664622 @default.
- W4236034797 hasRelatedWork W2296319024 @default.
- W4236034797 hasRelatedWork W2327443350 @default.
- W4236034797 hasRelatedWork W2400629228 @default.
- W4236034797 hasRelatedWork W2424199172 @default.
- W4236034797 hasRelatedWork W3030081434 @default.
- W4236034797 hasRelatedWork W618469773 @default.
- W4236034797 hasVolume "81" @default.
- W4236034797 isParatext "false" @default.
- W4236034797 isRetracted "false" @default.
- W4236034797 workType "article" @default.